Provided by Tiger Trade Technology Pte. Ltd.

Omeros

19.37
+0.62003.31%
Volume:91.22K
Turnover:1.75M
Market Cap:1.40B
PE:12.33
High:19.47
Open:18.97
Low:18.94
Close:18.75
52wk High:19.65
52wk Low:3.94
Shares:72.38M
Float Shares:67.73M
Volume Ratio:1.29
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.57
EPS(LYR):-0.0527
ROE:-576.33%
ROA:-18.68%
PB:-27.30
PE(LYR):-367.22

Loading ...

Top Omeros Executive Makes Eye-Catching Move With Insider Stock Sale

TIPRANKS
·
11 hours ago

Omeros VP, General Counsel Peter B. Cancelmo Sells USD 927,167 of Common Shares

Reuters
·
17 hours ago

Omeros Director Arnold C. Hanish Sells USD 189,713 of Common Shares

Reuters
·
Aug 29

Omeros VP Finance, CAO David J. Borges Reports Disposal of Common Shares Worth $206,935.60

Reuters
·
Aug 26

Insider Shake-Up at Omeros as Key Director Sells Off a Chunk of Shares

TIPRANKS
·
Aug 22

Omeros Director Thomas J. Cable Disposes of 15,000 Common Shares for $276,772.50

Reuters
·
Aug 22

Omeros Director Joseph L. Schocken Files Initial Beneficial Ownership Statement

Reuters
·
Aug 19

Why Omeros (OMER) Is Up 27.5% After Swinging To Profitability And Completing Share Buyback

Simply Wall St.
·
Aug 18

Omeros VP Finance, CAO David J. Borges Sells 5,000 Shares Worth $84,750

Reuters
·
Aug 18

Scienture Q2 Revenue Surges on Rezenopy Launch

Reuters
·
Aug 14

Omeros’ $100 Million Buyback Plan: How Discretionary Repurchases Could Distort Share Price and Heighten Volatility

TIPRANKS
·
Aug 14

Omeros Appoints Veteran Investor Joseph Schocken to Board

TIPRANKS
·
Aug 14

Omeros Appoints Tranceka Capital Founder Joseph Schocken to Board

Reuters
·
Aug 14

Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased

Reuters
·
Aug 14

ARS Pharmaceuticals Q2 Neffy Revenue Rises as Epinephrine Market Share Doubles

Reuters
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Biofrontera Q2 Revenue Rises on Higher Volume, Pricing

Reuters
·
Aug 13

CorMedix Beats Q2 Revenue Estimates on DefenCath Growth, Raises FY Adjusted Ebitda Guidance

Reuters
·
Aug 13

Karyopharm Q2 Revenue Falls as License Revenue Drops; Expects Funds to Last into September

Reuters
·
Aug 13

Pelthos Therapeutics Q2 Revenue Rises on Zelsuvmi Adoption

Reuters
·
Aug 13